Summary

Cell Culture Media Bags Market Research Report By Product Type (Stirred Tank Bioreactors, Wave Bioreactors, Gas Permeable Bags, Single-Use Bioreactors), By Capacity (Up to 50L, 50L to 500L, 500L to 1,000L, Over 1,000L), By Application (Monoclonal Antibody Production, Recombinant Protein Production, Cell-Based Therapy, Virus Propagation), By Material Type (Polypropylene, Polyethylene, Polystyrene, Biodegradable Materials), By Purification Stage (Process Development, Pilot Scale, Production Scale) and By Region Forecast to 2032

Market Overview
According to MRFR analysis, the cell culture media bags market was worth USD 1.11 billion in 2023. The sector is expected to expand from USD 1.17 billion in 2024 to USD 1.83 billion by 2032, with a compound annual growth rate (CAGR) of 5.77% over the forecast period (2024-2032).
Key market drivers for cell culture media bags include rising demand for cell-based therapeutics, increased usage of bioreactors in cell culture, and the requirement for efficient and cost-effective media storage and transportation. The market offers opportunities for the development of new biomaterials for media bags, the integration of sensors and monitoring systems, and expansion into new markets such as emerging economies. Recent trends in the cell culture medium bag market include a shift toward single-use systems, the use of new production methods, and an increased emphasis on sustainability and environmental effect.
Market Segment insights
The Cell Culture Media Bags Market is divided into four product types: stirred tank bioreactors, wave bioreactors, gas permeable bags, and single-use bioreactors.
The market is divided into capacity groups, which include 'Up to 50L', '50L to 500L', '500L to 1,000L', and 'Over 1,000L'.
The Cell Culture Media Bags Market is divided into four material types: polypropylene, polyethylene, polystyrene, and biodegradable materials.
The market segmentation by Purification Stage (Process Development, Pilot Scale, and Production Scale) provides useful insights into the industry's dynamics.
Regional insights
The Cell Culture Media Bags Market is divided into North America, Europe, APAC, South America, and MEA. North America is the largest regional segment, with more than 40% of the worldwide market in 2023. The region is home to many pharmaceutical and biotechnology industries, which are driving up demand for cell culture medium bags. Europe is the second largest regional category, with a market share of more than 30%. The region has a robust healthcare system and a thriving biopharmaceutical industry. APAC is the fastest-growing regional market, with a CAGR exceeding 5%. The region has various emerging markets, which are increasing demand for cell culture media bags. South America and Middle East and Africa are the smallest geographic divisions, accounting for less than 10% of the market. However, these locations are anticipated to expand significantly in the coming years.
Major Players
Cytiva, Merck KGaA, ATCC, STEMCELL Technologies, PromoCell GmBH, Himedia Laboratories Pvt. Ltd., Danaher, Corning, Lonza Group AG, BioVectra, BD Biosciences, Sartorius, Thermo Fisher Scientific, and GE Healthcare are among the key players in the Cell Culture Media Bags Market.

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
1.1. MARKET OVERVIEW
1.2. KEY FINDINGS
1.3. MARKET SEGMENTATION
1.4. COMPETITIVE LANDSCAPE
1.5. CHALLENGES AND OPPORTUNITIES
1.6. FUTURE OUTLOOK
2. MARKET INTRODUCTION
2.1. DEFINITION
2.2. SCOPE OF THE STUDY
2.2.1. RESEARCH OBJECTIVE
2.2.2. ASSUMPTION
2.2.3. LIMITATIONS
3. RESEARCH METHODOLOGY
3.1. OVERVIEW
3.2. DATA MINING
3.3. SECONDARY RESEARCH
3.4. PRIMARY RESEARCH
3.4.1. PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
3.4.2. BREAKDOWN OF PRIMARY RESPONDENTS
3.5. FORECASTING MODEL
3.6. MARKET SIZE ESTIMATION
3.6.1. BOTTOM-UP APPROACH
3.6.2. TOP-DOWN APPROACH
3.7. DATA TRIANGULATION
3.8. VALIDATION
4. MARKET DYNAMICS
4.1. OVERVIEW
4.2. DRIVERS
4.3. RESTRAINTS
4.4. OPPORTUNITIES
5. MARKET FACTOR ANALYSIS
5.1. VALUE CHAIN ANALYSIS
5.2. PORTER'S FIVE FORCES ANALYSIS
5.2.1. BARGAINING POWER OF SUPPLIERS
5.2.2. BARGAINING POWER OF BUYERS
5.2.3. THREAT OF NEW ENTRANTS
5.2.4. THREAT OF SUBSTITUTES
5.2.5. INTENSITY OF RIVALRY
5.3. COVID-19 IMPACT ANALYSIS
5.3.1. MARKET IMPACT ANALYSIS
5.3.2. REGIONAL IMPACT
5.3.3. OPPORTUNITY AND THREAT ANALYSIS
6. CELL CULTURE MEDIA BAGS MARKET, BY PRODUCT TYPE (USD BILLION)
6.1. STIRRED TANK BIOREACTORS
6.2. WAVE BIOREACTORS
6.3. GAS PERMEABLE BAGS
6.4. SINGLE-USE BIOREACTORS
7. CELL CULTURE MEDIA BAGS MARKET, BY CAPACITY (USD BILLION)
7.1. UP TO 50L
7.2. 50L TO 500L
7.3. 500L TO 1,000L
7.4. OVER 1,000L
8. CELL CULTURE MEDIA BAGS MARKET, BY APPLICATION (USD BILLION)
8.1. MONOCLONAL ANTIBODY PRODUCTION
8.2. RECOMBINANT PROTEIN PRODUCTION
8.3. CELL-BASED THERAPY
8.4. VIRUS PROPAGATION
9. CELL CULTURE MEDIA BAGS MARKET, BY MATERIAL TYPE (USD BILLION)
9.1. POLYPROPYLENE
9.2. POLYETHYLENE
9.3. POLYSTYRENE
9.4. BIODEGRADABLE MATERIALS
10. CELL CULTURE MEDIA BAGS MARKET, BY PURIFICATION STAGE (USD BILLION)
10.1. PROCESS DEVELOPMENT
10.2. PILOT SCALE
10.3. PRODUCTION SCALE
11. CELL CULTURE MEDIA BAGS MARKET, BY REGIONAL (USD BILLION)
11.1. NORTH AMERICA
11.1.1. US
11.1.2. CANADA
11.2. EUROPE
11.2.1. GERMANY
11.2.2. UK
11.2.3. FRANCE
11.2.4. RUSSIA
11.2.5. ITALY
11.2.6. SPAIN
11.2.7. REST OF EUROPE
11.3. APAC
11.3.1. CHINA
11.3.2. INDIA
11.3.3. JAPAN
11.3.4. SOUTH KOREA
11.3.5. MALAYSIA
11.3.6. THAILAND
11.3.7. INDONESIA
11.3.8. REST OF APAC
11.4. SOUTH AMERICA
11.4.1. BRAZIL
11.4.2. MEXICO
11.4.3. ARGENTINA
11.4.4. REST OF SOUTH AMERICA
11.5. MEA
11.5.1. GCC COUNTRIES
11.5.2. SOUTH AFRICA
11.5.3. REST OF MEA
12. COMPETITIVE LANDSCAPE
12.1. OVERVIEW
12.2. COMPETITIVE ANALYSIS
12.3. MARKET SHARE ANALYSIS
12.4. MAJOR GROWTH STRATEGY IN THE CELL CULTURE MEDIA BAGS MARKET
12.5. COMPETITIVE BENCHMARKING
12.6. LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE CELL CULTURE MEDIA BAGS MARKET
12.7. KEY DEVELOPMENTS AND GROWTH STRATEGIES
12.7.1. NEW PRODUCT LAUNCH/SERVICE DEPLOYMENT
12.7.2. MERGER & ACQUISITIONS
12.7.3. JOINT VENTURES
12.8. MAJOR PLAYERS FINANCIAL MATRIX
12.8.1. SALES AND OPERATING INCOME
12.8.2. MAJOR PLAYERS R&D EXPENDITURE. 2023
13. COMPANY PROFILES
13.1. CYTIVA
13.1.1. FINANCIAL OVERVIEW
13.1.2. PRODUCTS OFFERED
13.1.3. KEY DEVELOPMENTS
13.1.4. SWOT ANALYSIS
13.1.5. KEY STRATEGIES
13.2. MERCK KGAA
13.2.1. FINANCIAL OVERVIEW
13.2.2. PRODUCTS OFFERED
13.2.3. KEY DEVELOPMENTS
13.2.4. SWOT ANALYSIS
13.2.5. KEY STRATEGIES
13.3. ATCC
13.3.1. FINANCIAL OVERVIEW
13.3.2. PRODUCTS OFFERED
13.3.3. KEY DEVELOPMENTS
13.3.4. SWOT ANALYSIS
13.3.5. KEY STRATEGIES
13.4. STEMCELL TECHNOLOGIES
13.4.1. FINANCIAL OVERVIEW
13.4.2. PRODUCTS OFFERED
13.4.3. KEY DEVELOPMENTS
13.4.4. SWOT ANALYSIS
13.4.5. KEY STRATEGIES
13.5. PROMOCELL GMBH
13.5.1. FINANCIAL OVERVIEW
13.5.2. PRODUCTS OFFERED
13.5.3. KEY DEVELOPMENTS
13.5.4. SWOT ANALYSIS
13.5.5. KEY STRATEGIES
13.6. HIMEDIA LABORATORIES PVT. LTD.
13.6.1. FINANCIAL OVERVIEW
13.6.2. PRODUCTS OFFERED
13.6.3. KEY DEVELOPMENTS
13.6.4. SWOT ANALYSIS
13.6.5. KEY STRATEGIES
13.7. DANAHER
13.7.1. FINANCIAL OVERVIEW
13.7.2. PRODUCTS OFFERED
13.7.3. KEY DEVELOPMENTS
13.7.4. SWOT ANALYSIS
13.7.5. KEY STRATEGIES
13.8. CORNING
13.8.1. FINANCIAL OVERVIEW
13.8.2. PRODUCTS OFFERED
13.8.3. KEY DEVELOPMENTS
13.8.4. SWOT ANALYSIS
13.8.5. KEY STRATEGIES
13.9. LONZA GROUP AG
13.9.1. FINANCIAL OVERVIEW
13.9.2. PRODUCTS OFFERED
13.9.3. KEY DEVELOPMENTS
13.9.4. SWOT ANALYSIS
13.9.5. KEY STRATEGIES
13.10. BIOVECTRA
13.10.1. FINANCIAL OVERVIEW
13.10.2. PRODUCTS OFFERED
13.10.3. KEY DEVELOPMENTS
13.10.4. SWOT ANALYSIS
13.10.5. KEY STRATEGIES
13.11. BD BIOSCIENCES
13.11.1. FINANCIAL OVERVIEW
13.11.2. PRODUCTS OFFERED
13.11.3. KEY DEVELOPMENTS
13.11.4. SWOT ANALYSIS
13.11.5. KEY STRATEGIES
13.12. SARTORIUS
13.12.1. FINANCIAL OVERVIEW
13.12.2. PRODUCTS OFFERED
13.12.3. KEY DEVELOPMENTS
13.12.4. SWOT ANALYSIS
13.12.5. KEY STRATEGIES
13.13. THERMO FISHER SCIENTIFIC
13.13.1. FINANCIAL OVERVIEW
13.13.2. PRODUCTS OFFERED
13.13.3. KEY DEVELOPMENTS
13.13.4. SWOT ANALYSIS
13.13.5. KEY STRATEGIES
13.14. GE HEALTHCARE
13.14.1. FINANCIAL OVERVIEW
13.14.2. PRODUCTS OFFERED
13.14.3. KEY DEVELOPMENTS
13.14.4. SWOT ANALYSIS
13.14.5. KEY STRATEGIES
14. APPENDIX
14.1. REFERENCES
14.2. RELATED REPORTS